HOME >> MEDICINE >> NEWS
Reducing the costs of diabetes in Europe: Preventing complications is the key

Brussels, Belgium, Tuesday 28 September 1999: The first pan-European study to evaluate the overall cost of individuals with type 2 diabetes reveals that urgent action is needed to reduce the devastating long-term complications of the disease, if costs are to be kept under control.

"We are facing a potential crisis," warned Professor Massimo Massi-Benedetti, President of the International Diabetes Federation, European region, "the key to improving the quality of life of people with type 2 diabetes and to reducing future costs is to address the long-term complications of the disease."

Initial results from the CODE-2* (Costs of Diabetes in Europe--Type 2) study were presented today at a press briefing at the annual meeting of the European Association for the Study of Diabetes (EASD) in Brussels:

  • The total cost of more than 10 million individuals with type 2 diabetes in the countries studied was 29 billion Euros, which represents up to 7.4% or an average of 5% of the total healthcare expenditure in each country.
  • The overall cost to the healthcare system of an individual with type 2 diabetes is on average over 1.5 times higher than the general population.
  • Individuals with type 2 diabetes who have either small blood vessel complications, such as nerve damage or kidney problems, or large blood vessel complications, such as coronary heart disease, are twice as expensive to treat as individuals with no evidence of complications.
  • The presence of both types of complications increases costs by 3.5 times.
  • Hospitalisation costs, which include the treatment of long-term complications such as heart disease, account for 30-65% of the overall costs of patients with the disease--the largest proportion of costs.
  • Oral anti-diabetes medicines, which are the first line of type 2 diabetes treatment with medication, account for a relatively lower proportion of overall costs--only 2.7% of the total costs.
  • Other drugs, including insuli
    '"/>


Contact: Susie Hackett
susie@meditech.co.uk
44-171-404-7151
MediTech Media Ltd.
28-Sep-1999


Page: 1 2

Related medicine news :

1. Reducing hostility in young coronary artery disease patients is important piece of rehabilitation
2. Reducing anti-rejection meds after transplant shows less complications
3. Reducing the number of walk-in patients wont help solve emergency department overcrowding: Study
4. Reducing side effects of retinoic acid cancer treatment
5. Reducing hypertension in the elderly leads to a significant reduction in the incidence of stroke
6. Reducing antiepileptics in VNS (TM) patients does not impair seizure control
7. Reducing postoperative nausea and vomiting
8. Reducing the risk of medication errors: Announcing the Penn Center for Patient Safety Research and Practice
9. Reducing your risk of breast and ovarian cancer topic of womens cancer conference
10. Nurse Practitioners Reducing Costs, Expanding Care
11. Paying Attention To High Blood Pressure Programs A Good Investment In Reducing Stroke Risk

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/19/2017)... ... 19, 2017 , ... The Semper Fi Fund, one of the nation’s highest-rated ... series of videos and a compelling documentary that provide unique insights and powerful advice ... part of its ongoing mission. , Each of the videos focuses on a specific ...
(Date:9/19/2017)... , ... September 19, 2017 , ... ... searching for solutions to their neck and back pain with a reputable physician ... Allegion Spine Institute , formerly known as Nevada Spine Clinic was founded ...
(Date:9/19/2017)... Ontario (PRWEB) , ... September 19, 2017 , ... Public ... regulation of pollutants have fallen on deaf ears, leaving the water industry itself to ... company that stays ahead of the curve in the field of natural alkaline ...
(Date:9/19/2017)... ... September 19, 2017 , ... The ISO 9001 standard sets out the ... become more efficient and improve customer satisfaction. ISO 9001:2015 was released in 2015 and ... a deadline of September 2018. , As described in this white ...
(Date:9/19/2017)... , ... September 19, 2017 ... ... and cognitive health supplement developed by a neurosurgeon, has received a big ... , Daily Brain Booster is currently available on the Wal-Mart Stores-owned ...
Breaking Medicine News(10 mins):
(Date:9/9/2017)... INDIANAPOLIS , Sept. 9, 2017  Eli Lilly ... key primary and secondary endpoint data for lasmiditan, an ... migraine, which demonstrated statistically significant improvements compared to placebo ... be highlighted today at the 18th Congress of the ... . "The data presented today demonstrate lasmiditan,s ...
(Date:9/7/2017)... Texas , Sept. 7, 2017 ... science focused on fulfilling the promise of precision ... further validate the benefits of its molecular profiling ... study utilized comprehensive genomic profiling plus (CGP+) with ... individual patient,s tumor on a molecular level, leading ...
(Date:9/7/2017)... , Sept. 7, 2017   BioLife Solutions , ... and marketer of proprietary clinical grade cell and tissue ... announces that Mike Rice , President and CEO, will ... Rodman & Renshaw 19 th Annual ... Eastern time (12:25 p.m. Pacific time). The conference is being ...
Breaking Medicine Technology:
Cached News: